In its COVID-19 Update report, Kalorama Information said that volume was up in labs and among IVD vendors, new technologies are available. Kalorama projects a 10.5 billion-dollar market for COVID-19. This is a 1 billion dollar increase from previous estimates. For most aspects of the diagnostic testing process, there has still been a learning curve […]
The microbiome is a rapidly growing market. Understanding the detailed roles and functions of the microbiome is important as it is linked to a multitude of critical areas from human health to environmental sustainability. (A recent report on “Analytics of the Microbiome” by Arogyam covers all aspects of the microbiome landscape. A free preview of the […]
It’s an oft-told story that the fortune of Swedish chemist and businessman Alfred Nobel was founded on patented explosives, including dynamite. While his products were used beneficially in mining and construction applications, their wartime use in munitions gave him concern that he would be remembered solely as a ‘merchant of death’. Consequently, Nobel set aside […]
What is a Lab-Developed Test? In vitro diagnostic (IVD) tests are manufactured and sold by diagnostic companies following approval (or clearance) by the appropriate regulatory agencies. IVD tests are then distributed and used by many different clinical laboratories. In contrast, a laboratory developed test (LDTs) is developed by a clinical laboratory for use specifically in […]
Urgent care’s story in the United States has been all about growth. They offer walk-in care and a range of services, expanded hours and limited wait times. They usually have imaging equipment and multiple providers and are in a freestanding location or a dedicated store within a retail strip mall. With approximately 10,000 locations across […]
It’s beyond theory. The microbiome is one of many trends that align well with the IVD market. It is explored in Kalorama Information’s study of the in vitro diagnostic market, The Worldwide Market for In Vitro Diagnostic Tests along with other trends such as automation and gene editing. The continuous search of the etiology of […]
Demand for testing has gone from a healthcare industry topic to a national crusade in weeks with the onset of COVID-19. High-throughput tests have been approved by the U.S. Food and Drug Administration (FDA) for use in the U.S. for the detection of SARS-CoV-2, the virus behind the disease. But for true intervention in doctors […]
Not since the Swine Flu epidemic of 2009 has there been this amount of emphasis on vaccines and vaccine development. This new infectious disease threat with no anti-viral, nor vaccine is causing significant concern among healthcare providers, governments and the public. Last-resort measures such as school closings and curfews in place in the United States […]
A rapid scale-up of diagnostic testing for the novel coronavirus was the focus of a declaration of emergency by President Donald Trump in a March 13 press conference. The plan calls for sharply boosting the production of coronavirus test kits while also making tests available at a network of drive-through sites. In an address at the […]
Molecular point-of-care diagnostic solutions offer improvements in the sensitivity and specificity of existing near-patient and rapid tests while expanding the diagnostic capabilities at points of care, such as hospital critical care units, physician offices, outpatient clinics, and community health posts in the developing world, and are used to assess conditions or admit patients. The concept […]
